Cognition Therapeutics, Inc. Common Stock (NASDAQ: CGTX) last traded at $0.877, down 2.04% on the session. The quote above updates while this page is open; the figures below are drawn from Cognition Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Cognition Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker CGTX. Its market capitalisation is $83.39 million.
Valuation measures for Cognition Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $83.39M |
|---|---|
| Enterprise value | $55.25M |
| Price / book | 2.53 |
| Beta | 2.69 |
Trailing-twelve-month figures tagged in Cognition Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$16.77M |
| EPS (TTM) | -$0.160 |
|---|
| Return on equity | -50.80% |
|---|
| Cash | $34.01M |
|---|
Range and volume for CGTX over the past 52 weeks.
| 52-week high | $2.00 |
|---|---|
| 52-week low | $0.550 |
| Volume | 316.9K |
| Average volume | 531.3K |
| Previous close | $0.895 |
Invest a chosen dollar amount in Cognition Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CGTX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.